CyFlow™ Bcl2 PE

CyFlow™ Bcl2 PE

Catalog Number:
A001342979SYS
Mfr. No.:
AE483629
Price:
$488
  • Size:
    100 tests (2.0 mL)
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          Bcl2 (B cell CLL lymphoma 2) is a proto-oncogen, which can contribute to tumorigenesis by counteracting apoptosis in various cell types. The anti-apoptotic effect of Bcl2 is performed by its interactions with suppressors and agonists of cell death and under physiological conditions it is regulated by proteolytic processing and phosphorylation. Bcl2 expression can be detected mainly in lymphoid tissues and in the basal cells of epithelial tissues. It is also a marker that can help in classification of lymphoproliferative diseases and in prognostics of some epithelial neoplasms.

      • Properties
        • Host
          mouse
          Antibody Type
          monoclonal
          Isotype
          IgG1
          Reactivity
          human
          Clone
          Bcl-2/100
          Immunogen
          Synthetic peptide corresponding to the amino acids 41-54 of human Bcl2
          Conjugate
          PE
          Formulation
          The reagent is provided in stabilizing phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
          Storage
          Avoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
          Regulatory Status
          RUO

          * Research use only

      • Applications
        • Application
          Flow Cytometry
          Application Description
          The reagent is designed for Flow Cytometry analysis of human blood cells. Recommended usage is 20·µl reagent·/ 100·µl of whole blood or 10^6 cells in a suspension. The content of a vial (2 ml) is sufficient for 100 tests.

          Emission Maximum: 576 nm
          Excitation Maximum: 496 nm, 565 nm

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.